Sireesh Appajosyula - Jan 11, 2022 Form 3 Insider Report for Hillstream BioPharma Inc. (HILS)

Role
Director
Signature
/s/ Randy Milby as Attorney-In-Fact for Sireesh Appajosyula
Stock symbol
HILS
Transactions as of
Jan 11, 2022
Transactions value $
$0
Form type
3
Date filed
1/11/2022, 08:48 PM
Next filing
Mar 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HILS Common stock 284K Jan 11, 2022 Direct
holding HILS Common stock 972K Jan 11, 2022 See footnote F1
holding HILS Common stock 75.8K Jan 11, 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HILS Options (right to purchase) Jan 11, 2022 Common stock 37.9K $0.08 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock are owned by Highpoint Pharmaceuticals LLC. Sireesh Appajosyula is the Managing Member of Highpoint Pharmaceuticals LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
F2 The shares of common stock are owned by Mercer Lake Group LLC. Sireesh Appajosyula is the is the Managing Member of Mercer Lake Group LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
F3 The Registrant issued the Reporting Person the options on August 30, 2019. The options vested immediately upon grant and become exercisable upon (i) consummation of the Registrant's initial public offering of its securities or (ii) consummation of a reverse merger of the Registrant with and into a public company.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney